Science Research And
Innovation

Science, Research and Innovation

At Psoriasis Eczema Clinic, we are dedicated to continuously grow and share our knowledge of the latest developments in science, research and innovation in Integrative Dermatology.

Clinic founder, Prof. Michael Tirant (PhD), has been involved in dermatology research for over 30 years, investigating triggers of a number of chronic skin diseases. In the early 80s, his research showed that alcohol and tobacco smoking exacerbate psoriasis, while diet and nutrition play major roles in the management of the disease. He also found that some of the triggers were blood group related and this work was published in Dermatologic Therapy journal.

Thankfully, the evidence continues to grow and support these findings, validating the importance of managing detrimental lifestyle factors such as poor sleep quality, unhealthy diet, stress and environmental exposure when treating chronic skin diseases.

Our research and development team focuses primarily on exploring the actions of various herbal bioactive compounds, including how they can heal the skin and be applied through therapeutic topical treatments . Staying up to date with the latest research around skin physiology, including the microbiome, provides opportunities for new, ground-breaking approaches and delivery methods in skin treatment.

Prof. Tirant frequently collaborates with international universities and hospitals, educating doctors and dermatologists on the benefits of Integrative Dermatology protocols for the treatment and management of severe skin conditions.

As a pioneer in developing Integrative Treatment protocols in dermatology , Prof. Tirant believes that the patient is always the most important and that practitioners should be open to different approaches , for the best possible treatment outcome and management of chronic skin disorders. What works for one patient, does not necessarily work on another. So, we should all work together for the benefit of the patient.

30+ Years of Personalised Skin Treatment

Our treatments have been trialed extensively by a number of independent dermatology Professors worldwide. These trials have confirmed a success rate of up to 90% in Psoriasis and 84% in eczema*

* JBRHA Vol.30, No2 (S3), April-June 2016